Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Raghdaa Hamdan, Al Zarzour"'
Autor:
Salah Abdulrazak Alshehade, Raghdaa Hamdan Al Zarzour, Vikneswaran Murugaiyah, Sharoen Yu Ming Lim, Huda Ghaleb El-Refae, Mohammed Abdullah Alshawsh
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 11, Pp 1572-1588 (2022)
Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of a metabolic syndrome caused by excessive accumulation of fat in the liver. Orthosiphon stamineus also known as Orthosiphon aristatus is a medicinal plant with possib
Externí odkaz:
https://doaj.org/article/3601ca2f29244fd69c0639f0e4baac8d
Autor:
Raghdaa Hamdan Al Zarzour, Ezatul Ezleen Kamarulzaman, Fadi G. Saqallah, Fauziahanim Zakaria, Muhammad Asif, Khairul Niza Abdul Razak
Publikováno v:
Heliyon, Vol 8, Iss 9, Pp e10665- (2022)
Extensive attention has been focused on herbal medicine for the treatment of different endocrine disorders. In fact, compelling scientific evidence indicates that natural compounds might act as endocrine modulators by mimicking, stimulating, or inhib
Externí odkaz:
https://doaj.org/article/01d8f2fdc05b45efbfed05afc4889da5
Autor:
Salah Abdalrazak Alshehade, Raghdaa Hamdan Al Zarzour, Michael Mathai, Nelli Giribabu, Atefehalsadat Seyedan, Gurjeet Kaur, Fouad Saleih Resq Al-Suede, Amin Malik Shah Abdul Majid, Vikneswaran Murugaiyah, Hassan Almoustafa, Mohammed Abdullah Alshawsh
Publikováno v:
Pharmaceuticals, Vol 16, Iss 1, p 109 (2023)
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of liver disease. Orthosiphon aristatus (Blume) Miq, a traditional plant in South Asia, has previously been shown to attenuate obesity and hyperglycaemic conditions. Eight weeks of
Externí odkaz:
https://doaj.org/article/d4caa0ab56b84251981e8340954023b4
Autor:
Mohammed Abdullah Alshawsh, Abdulsamad Alsalahi, Salah Abdalrazak Alshehade, Sultan Ayesh Mohammed Saghir, Ahmad Faheem Ahmeda, Raghdaa Hamdan Al Zarzour, Ayman Moawad Mahmoud
Publikováno v:
Molecules, Vol 27, Iss 3, p 858 (2022)
Non-alcoholic fatty liver disease (NAFLD) embraces several forms of liver disorders involving fat disposition in hepatocytes ranging from simple steatosis to the severe stage, namely, non-alcoholic steatohepatitis (NASH). Recently, several experiment
Externí odkaz:
https://doaj.org/article/ec5c07f7d9654818a15adba353376d1b
Autor:
Abdul Rahman Mahmoud F. Nahas, Raghdaa Hamdan Al Zarzour, Asmaa Salama M. Abu Laila, Ahmed Mahmoud Tabash, Ayman Mustafa Abu Mustafa, Faten Mohamad Allyan, Abdrabbou Mohammed Elregeb, Eyad Elabed Muadi Abou Teior, Abdulkareem Mohammed Al-Shami, Mohamed Hassan Elnaem
Publikováno v:
Journal of Renal Injury Prevention.
Introduction: Patients with end-stage renal disease (ESRD) are predisposed to nutritional deficiencies, resulting in vitamin B12 deficiency with negative hematologic consequences. Objective: This study aimed to investigate the impact of intramuscular
Autor:
Salah Alshehade, Mohammed Abdullah Alshawsh, Vikneswaran Murugaiyah, Muhammad Asif, Omayma Alshehade, Hassan Almoustafa, Raghdaa Hamdan Al Zarzour
Publikováno v:
Life Sciences. 305:120732
Metabolic dysfunction-associated fatty liver disease (MAFLD), proposed in 2020 is a novel term for non-alcoholic fatty liver disease (NAFLD) which was coined for the first time in 1980. It is a leading cause of the most chronic liver disease and hepa
Autor:
Dhamraa W, Al-Dulaimi, Aman, Shah Abdul Majid, Hussein, M Baharetha, Mohamed B Khadeer, Ahamed, Sarah Furqan, Faisal, Raghdaa Hamdan, Al Zarzour, Chern, Ein Oon, Amin Malik Shah, Abdul Majid, Loiy E, Ahmed Hassan
Publikováno v:
Drug and chemical toxicology. 45(2)